Tuning beneficial calcineurin phosphatase activation to counter α-synuclein toxicity in a yeast model of Parkinson's disease

被引：0
|
作者：
Srishti Chawla [1 ,2 ]
Mikael Molin [2 ]
Thomas Nystrom [1 ]
机构：
[1] Institute for Biomedicine,Sahlgrenska Academy,Centre for Ageing and Health-Age Cap,University of Gothenburg
[2] Department of Life Sciences,Chalmers University of Technology
来源：
Neural Regeneration Research | 2025年 / 01期
关键词：
D O I：
暂无
中图分类号：
R742.5 [震颤麻痹综合征];
学科分类号：
1002 ;
摘要：
Calcineurin(CN) is a calcium-and calmodulindependent serine/threonine that has been studied in many model organisms including yeast, filamentous fungi, plants, and mammals. Its biological functions range from ion homeostasis and virulence in lower eukaryotes to T-cell activation in humans by human nuclear factors of activated T-cells. CN is a heterodimeric protein consisting of a catalytic subunit,
引用
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [31] Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
    Rupsha Mondal
    Chayan Banerjee
    Sumangal Nandy
    Moumita Roy
    Joy Chakraborty
    Cell & Bioscience, 13
  • [32] Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson's disease model
    Mondal, Rupsha
    Banerjee, Chayan
    Nandy, Sumangal
    Roy, Moumita
    Chakraborty, Joy
    CELL AND BIOSCIENCE, 2023, 13 (01):
  • [33] Microglia and astrocyte activation is region-dependent in the α-synuclein mouse model of Parkinson's disease
    Basurco, Leyre
    Angel Abellanas, Miguel
    Ayerra, Leyre
    Conde, Enrique
    Vinueza-Gavilanes, Rodrigo
    Luquin, Esther
    Vales, Africa
    Vilas, Amaya
    San Martin-Uriz, Patxi
    Tamayo, Ibon
    Alonso, Marta M.
    Hernaez, Mikel
    Gonzalez-Aseguinolaza, Gloria
    Clavero, Pedro
    Mengual, Elisa
    Arrasate, Montserrat
    Hervas-Stubbs, Sandra
    Aymerich, Maria S.
    GLIA, 2023, 71 (03) : 571 - 587
  • [34] Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson's disease
    Izco, Maria
    Blesa, Javier
    Verona, Guglielmo
    Cooper, J. Mark
    Alvarez-Erviti, Lydia
    NEUROSCIENCE RESEARCH, 2021, 170 : 330 - 340
  • [35] Interplay of post-translational modifications of α-synuclein in yeast model of Parkinson disease
    Shahpasandzadeh, Hedieh
    Popova, Blagovesta
    Braus, Gerhard
    YEAST, 2013, 30 : 80 - 80
  • [36] The AAV-a-Synuclein a-Synuclein Model of Parkinson's Disease: An Update
    Bjorklund, Anders
    Mattsson, Bengt
    JOURNAL OF PARKINSONS DISEASE, 2024, 14 (06) : 1077 - 1094
  • [37] Harnessing the power of yeast to decipher the role of α-synuclein phosphorylation in Parkinson's disease
    Tenreiro, Sandra
    Reimao-Pinto, Madalena M.
    Antas, Pedro
    Rino, Jose
    Waiss, Meytal
    Magalhaes, Filipa
    Wawrzycka, Donata
    Macedo, Diana
    Cunha, Monica E.
    Kaganovich, Daniel
    Outeiro, Tiago F.
    YEAST, 2013, 30 : 79 - 79
  • [38] Isradipine rescues alpha-synuclein toxicity in a zebrafish model of Parkinson's disease by upregulating autophagy
    Stahl, M. C.
    Prabhudesai, S.
    Lulla, A.
    Bronstein, J.
    MOVEMENT DISORDERS, 2015, 30 : S47 - S48
  • [39] Effects of α-synuclein immunization in a mouse model of Parkinson's disease
    Masliah, E
    Rockenstein, E
    Adame, A
    Alford, M
    Crews, L
    Hashimoto, M
    Seubert, P
    Lee, M
    Goldstein, J
    Chilcote, T
    Games, D
    Schenk, D
    NEURON, 2005, 46 (06) : 857 - 868
  • [40] ISOLATION OF ACTIVE CONSTITUENT AGAINST α-SYNUCLEIN TOXICITY FOR PARKINSON'S DISEASE TREATMENT
    Sushruta, K.
    Shin, K. Y.
    Noh, S. J.
    Suh, Y. H.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 262 - 262
12345